Sign In
Buy OCUP
$1.17
+0 (+0%)
At Close: Jan 22, 2025
Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase
08:00am, Thursday, 26'th Oct 2023
FARMINGTON HILLS, Mich., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-m
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
08:00am, Friday, 06'th Oct 2023
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy
Viatris and Ocuphire Pharma get FDA green light for eye treatment
08:21am, Wednesday, 27'th Sep 2023
Viatris Inc. VTRS, and Ocuphire Pharma Inc. OCUP, +3.08% said Wednesday that the U.S. Food and Drug Administration has approved Ryzumvi to treat the side effects of pharmacologically-induced mydriasis
Ocuphire Pharma to Present at the Canaccord 43rd Annual Growth Conference and the H.C. Wainwright Ophthalmology Conference in August
08:00am, Tuesday, 08'th Aug 2023
FARMINGTON HILLS, Mich., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-m
Surprise! These 3 Penny Stocks Pack Powerful Financials.
08:42pm, Monday, 10'th Jul 2023
Penny stocks have a horrible reputation for the most part and it's not necessarily undeserved. Too many times, charlatans hawk their junk securities, often in the over-the-counter market where regulat
PHIO's Skin Cancer Candidate to Enter Clinical Study, Stock Up
12:47pm, Wednesday, 17'th May 2023
PHIO surges on the FDA clearance of investigational new drug application for its lead product, PH-762, for the treatment of skin carcinomas.
The 7 Best Stocks Under $10 to Buy in May
02:10pm, Wednesday, 03'rd May 2023
While the adage that you get what you pay for generally rings true, you can sometimes cheat up this narrative with the best stocks to buy under $10. While you can't get much for a Hamilton these days,
7 Small-Cap Biotech Stocks with Massive Potential
06:36pm, Thursday, 27'th Apr 2023
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappo
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case - Ocuphire Pharma (NASDAQ:OCUP)
03:07pm, Friday, 21'st Apr 2023
Ocuphire Pharma Inc OCUP was plunging over 22% at one point on Friday after the company announced it appointed Rick Rodgers to the role of interim CEO. An SEC filing, which stated former CEO Mina So
Wall Street Analysts Believe Ocuphire Pharma, Inc. (OCUP) Could Rally 257.14%: Here's is How to Trade
11:25am, Friday, 21'st Apr 2023
The consensus price target hints at a 257.1% upside potential for Ocuphire Pharma, Inc. (OCUP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ear
Ocuphire Pharma, Inc. (OCUP) Is a Great Choice for 'Trend' Investors, Here's Why
09:55am, Friday, 21'st Apr 2023
Ocuphire Pharma, Inc. (OCUP) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Ocuphire Pharma, Inc. (OCUP) is a Great Momentum Stock: Should You Buy?
01:43pm, Thursday, 20'th Apr 2023
Does Ocuphire Pharma, Inc. (OCUP) have what it takes to be a top stock pick for momentum investors? Let's find out.
As Ocuphire Pharma Rally Gathers Steam Post-Results, What Did Investors Initially Miss?
10:28pm, Wednesday, 05'th Apr 2023
Clinical-stage ophthalmic biopharmaceutical company Ocuphire Pharma, Inc. (US:OCUP) announced its fourth-quarter and year-end financial results on March 30, indicating a successful year with signific
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
01:40pm, Wednesday, 05'th Apr 2023
While it might be difficult to navigate the equities sector now amid various headwinds, biotech stocks to buy may offer a surprising respite. True, the market presence of the surprise production cuts
Does Ocuphire Pharma, Inc. (OCUP) Have the Potential to Rally 323.89% as Wall Street Analysts Expect?
11:26am, Wednesday, 05'th Apr 2023
The mean of analysts' price targets for Ocuphire Pharma, Inc. (OCUP) points to a 323.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement
